Your browser doesn't support javascript.
loading
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.
Shingai, Masashi; Donau, Olivia K; Plishka, Ronald J; Buckler-White, Alicia; Mascola, John R; Nabel, Gary J; Nason, Martha C; Montefiori, David; Moldt, Brian; Poignard, Pascal; Diskin, Ron; Bjorkman, Pamela J; Eckhaus, Michael A; Klein, Florian; Mouquet, Hugo; Cetrulo Lorenzi, Julio Cesar; Gazumyan, Anna; Burton, Dennis R; Nussenzweig, Michel C; Martin, Malcolm A; Nishimura, Yoshiaki.
Afiliação
  • Shingai M; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Donau OK; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Plishka RJ; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Buckler-White A; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Mascola JR; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Nabel GJ; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Nason MC; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
  • Montefiori D; Department of Surgery, Duke University Medical Center, Durham, NC 27710.
  • Moldt B; Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for HIV/AIDS Vaccine immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037 Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for
  • Poignard P; Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for HIV/AIDS Vaccine immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037 Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for
  • Diskin R; Department of Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
  • Bjorkman PJ; Division of Biology, California Institute of Technology, Pasadena, CA 91125 Howard Hughes Medical Institute, Chevy Chase, MD 20815.
  • Eckhaus MA; Diagnostic and Research Services Branch, Office of the Director, National Institutes of Health, Bethesda, MD 20892.
  • Klein F; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
  • Mouquet H; Laboratory of Humoral Response to Pathogens, Department of Immunology, Institut Pasteur, 75724 Paris, France.
  • Cetrulo Lorenzi JC; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
  • Gazumyan A; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
  • Burton DR; Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for HIV/AIDS Vaccine immunology and Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037 Department of Immunology and Microbial Science, IAVI Neutralizing Antibody Center, and Center for
  • Nussenzweig MC; Howard Hughes Medical Institute, Chevy Chase, MD 20815 Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065.
  • Martin MA; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 malm@nih.gov ynishimura@niaid.nih.gov.
  • Nishimura Y; Laboratory of Molecular Microbiology, Virology Laboratory, Vaccine Research Center, and Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 malm@nih.gov ynishimura@niaid.nih.gov.
J Exp Med ; 211(10): 2061-74, 2014 Sep 22.
Article em En | MEDLINE | ID: mdl-25155019
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Anticorpos Anti-HIV / Infecções por Lentivirus / HIV / Vírus da Imunodeficiência Símia / Anticorpos Neutralizantes / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Anticorpos Anti-HIV / Infecções por Lentivirus / HIV / Vírus da Imunodeficiência Símia / Anticorpos Neutralizantes / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Animals / Humans Idioma: En Revista: J Exp Med Ano de publicação: 2014 Tipo de documento: Article